VRG-201

N/A

Report date: 2024/12/23 17:44:46

NMEFirst In Class

Base Information

Drug NameVRG-201

Drug Alias NameVRG201VRG-201

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionLymphocyte differentiation antigen CD38 inhibitors

TargetsLymphocyte differentiation antigen CD38

Therapy Area/IndicationsObesity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVerge Genomics Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsObesity

Inactive IndicationsN/A

ATC CodeN/A